|
1
|
The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.
|
Ann Intern Med
|
2004
|
3.05
|
|
2
|
Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004.
|
AIDS
|
2005
|
2.42
|
|
3
|
Sex differences in pharmacokinetics and pharmacodynamics.
|
Annu Rev Pharmacol Toxicol
|
2004
|
2.17
|
|
4
|
Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2007
|
2.11
|
|
5
|
Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols.
|
AIDS
|
2005
|
2.03
|
|
6
|
The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women.
|
J Acquir Immune Defic Syndr
|
2005
|
1.96
|
|
7
|
The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.
|
AIDS
|
2011
|
1.94
|
|
8
|
Factors associated with use of dental services among HIV-infected and high-risk uninfected women.
|
J Am Dent Assoc
|
2005
|
1.79
|
|
9
|
Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women.
|
J Acquir Immune Defic Syndr
|
2003
|
1.78
|
|
10
|
Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.
|
Arch Intern Med
|
2002
|
1.75
|
|
11
|
Does patient sex affect human immunodeficiency virus levels?
|
Clin Infect Dis
|
2002
|
1.72
|
|
12
|
Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy.
|
Clin Infect Dis
|
2011
|
1.70
|
|
13
|
Protease inhibitor levels in hair strongly predict virologic response to treatment.
|
AIDS
|
2009
|
1.68
|
|
14
|
Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2004
|
1.66
|
|
15
|
The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection.
|
Haematologica
|
2006
|
1.53
|
|
16
|
Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection.
|
Cancer Res
|
2004
|
1.50
|
|
17
|
Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV.
|
AIDS
|
2016
|
1.45
|
|
18
|
Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry.
|
Rapid Commun Mass Spectrom
|
2008
|
1.44
|
|
19
|
Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART.
|
J Womens Health (Larchmt)
|
2009
|
1.41
|
|
20
|
Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study.
|
J Acquir Immune Defic Syndr
|
2002
|
1.35
|
|
21
|
The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use.
|
Addiction
|
2005
|
1.32
|
|
22
|
Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study.
|
J Acquir Immune Defic Syndr
|
2005
|
1.31
|
|
23
|
CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women.
|
J Infect Dis
|
2003
|
1.29
|
|
24
|
Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.
|
Hepatology
|
2010
|
1.28
|
|
25
|
The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women's interagency HIV study.
|
J Acquir Immune Defic Syndr
|
2006
|
1.24
|
|
26
|
Hair it is: the long and short of monitoring antiretroviral treatment.
|
Ann Intern Med
|
2002
|
1.22
|
|
27
|
Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry.
|
Anal Bioanal Chem
|
2011
|
1.18
|
|
28
|
Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy.
|
AIDS
|
2004
|
1.18
|
|
29
|
A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women.
|
J Infect Dis
|
2012
|
1.17
|
|
30
|
The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review.
|
Patient Prefer Adherence
|
2012
|
1.15
|
|
31
|
Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
|
Am J Drug Alcohol Abuse
|
2008
|
1.14
|
|
32
|
The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.
|
J Infect Dis
|
2011
|
1.13
|
|
33
|
Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women.
|
AIDS
|
2009
|
1.12
|
|
34
|
Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations.
|
AIDS
|
2006
|
1.11
|
|
35
|
Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.
|
J Acquir Immune Defic Syndr
|
2009
|
1.10
|
|
36
|
Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons.
|
Prev Med
|
2010
|
1.08
|
|
37
|
Mentoring early-career scientists for HIV research careers.
|
Am J Public Health
|
2009
|
1.08
|
|
38
|
Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women.
|
AIDS
|
2014
|
1.06
|
|
39
|
Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy.
|
Am J Epidemiol
|
2005
|
1.06
|
|
40
|
The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.
|
PLoS One
|
2013
|
1.06
|
|
41
|
Variations in serum müllerian inhibiting substance between white, black, and Hispanic women.
|
Fertil Steril
|
2008
|
0.99
|
|
42
|
Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data.
|
Virol J
|
2010
|
0.96
|
|
43
|
Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women.
|
J Womens Health (Larchmt)
|
2006
|
0.96
|
|
44
|
Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women.
|
J Acquir Immune Defic Syndr
|
2008
|
0.96
|
|
45
|
Phenotype and functionality of CD4+ and CD8+ T cells in the upper reproductive tract of healthy premenopausal women.
|
Am J Reprod Immunol
|
2013
|
0.96
|
|
46
|
HIV tropism and decreased risk of breast cancer.
|
PLoS One
|
2010
|
0.94
|
|
47
|
The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts.
|
Sex Transm Dis
|
2002
|
0.93
|
|
48
|
Underlying genetic structure impacts the association between CYP2B6 polymorphisms and response to efavirenz and nevirapine.
|
AIDS
|
2012
|
0.93
|
|
49
|
Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease.
|
Am J Respir Crit Care Med
|
2015
|
0.93
|
|
50
|
Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women.
|
AIDS
|
2013
|
0.93
|
|
51
|
Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts.
|
BMC Pulm Med
|
2014
|
0.93
|
|
52
|
HIV infection is associated with diffusing capacity impairment in women.
|
J Acquir Immune Defic Syndr
|
2013
|
0.91
|
|
53
|
Correlates of CD4+ and CD8+ lymphocyte counts in high-risk immunodeficiency virus (HIV)-seronegative women enrolled in the women's interagency HIV study (WIHS).
|
Hum Immunol
|
2007
|
0.91
|
|
54
|
Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy.
|
J Virol
|
2011
|
0.91
|
|
55
|
Investigation of menopausal stage and symptoms on cognition in human immunodeficiency virus-infected women.
|
Menopause
|
2014
|
0.91
|
|
56
|
Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women.
|
Fertil Steril
|
2007
|
0.89
|
|
57
|
Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications.
|
Am J Reprod Immunol
|
2011
|
0.87
|
|
58
|
Increased circulating interleukin-7 levels in HIV-1-infected women.
|
J Acquir Immune Defic Syndr
|
2005
|
0.87
|
|
59
|
Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women: a report from the Women's Interagency HIV Study.
|
J Subst Abuse Treat
|
2005
|
0.86
|
|
60
|
HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients.
|
AIDS
|
2014
|
0.86
|
|
61
|
Mentoring the next generation of HIV prevention researchers: a model mentoring program at the University of California San Francisco and Gladstone Institute of Immunology and Virology Center for AIDS research.
|
J Acquir Immune Defic Syndr
|
2008
|
0.84
|
|
62
|
Incidence of tuberculin skin test conversion among HIV-infected and -uninfected women: results of a 6-year study.
|
J Acquir Immune Defic Syndr
|
2006
|
0.83
|
|
63
|
Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia.
|
Obstet Gynecol
|
2012
|
0.83
|
|
64
|
Gonadotropin and sex steroid levels in HIV-infected premenopausal women and their association with subclinical atherosclerosis in HIV-infected and -uninfected women in the women's interagency HIV study (WIHS).
|
J Clin Endocrinol Metab
|
2013
|
0.82
|
|
65
|
Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women.
|
Menopause
|
2012
|
0.82
|
|
66
|
Impact of menopause on condom use by HIV-seropositive and comparison seronegative women.
|
J Acquir Immune Defic Syndr
|
2008
|
0.82
|
|
67
|
Impact of CD4+ lymphocytes and HIV infection on Anti-Müllerian Hormone levels in a large cohort of HIV-infected and HIV-uninfected women.
|
Am J Reprod Immunol
|
2014
|
0.81
|
|
68
|
Lower levels of interleukin-12 precede the development of tuberculosis among HIV-infected women.
|
Cytokine
|
2011
|
0.81
|
|
69
|
Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability.
|
AIDS
|
2011
|
0.79
|
|
70
|
CCR2 genotype and disease progression in a treated population of HIV type 1-infected women.
|
Clin Infect Dis
|
2004
|
0.79
|
|
71
|
Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection.
|
J Infect Dis
|
2012
|
0.78
|
|
72
|
Hair changes in women from the Women's Interagency HIV Study.
|
Arch Dermatol
|
2003
|
0.77
|
|
73
|
Elevated caspase-3 expression and T-cell activation in elite suppressors.
|
J Acquir Immune Defic Syndr
|
2010
|
0.76
|
|
74
|
In vivo effects of nonoxynol-9 on endometrial immune cell populations.
|
J Acquir Immune Defic Syndr
|
2009
|
0.76
|
|
75
|
Pharmacist counseling in a cohort of women with HIV and women at risk for HIV.
|
Patient Prefer Adherence
|
2012
|
0.76
|
|
76
|
Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART.
|
AIDS Care
|
2011
|
0.75
|
|
77
|
Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
78
|
Human herpesvirus 8, Kaposi's sarcoma, and associated conditions.
|
Clin Lab Med
|
2002
|
0.75
|